Summary
The present study was aimed at determining the generation of ‘prostacyclin (PGI2)-like-material’ in coronary arteries from normal and diabetic (pancreatectomized) dogs as well as the contractile responses to prostacyclin of preparations from normal, diabetic and insulin-treated diabetic animals. PGI2 produced a dose-dependent relaxation of coronary arteries from normal dogs. In contrast, those from diabetic animals were not relaxed; indeed, at low concentrations PGI2 failed to evoke any effect but at higher ones it induced a distinct contraction. In arteries from diabetic animals treated with insulin, PGI2 induced a biphasic contractile effect, which lay between that of normal controls and untreated diabetics. In addition the basal generation of ‘PGI2-like-material’ by coronary arteries was significantly higher in the diabetic (141±0.2 pg/mg, mean±SEM) than in normal dogs (59±0.2 pg/mg). The present experiments demonstrate that the generation of ‘PGI2-like-substance’ is significantly increased in coronary arteries from diabetic dogs, but the same vessels are unable to respond to added authentic PGI2 with relaxation; on the contrary they react with a distinct positive contractile response.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Moncada S, Higgs EA, Vane JR (1977) Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1:18–20
Dusting GF, Moncada S, Vane JR (1977) Prostacyclin is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins 13:3–15
Schrör K, Moncada S, Ubatuba FB, Vane JR (1977) Formation of prostacyclin causes decrease in coronary vascular resistance during application of arachidonic acid in the rabbit isolated heart. Naunyn Schmiedeberg's Arch Pharmacol 297:R31
Schrör K, Moncada S, Ubatuba FB, Vane JR (1978) Transformation of arachidonic acid and prostaglandin endoperoxide by the guinea pig heart. Formation of RCS and prostacyclin. Eur J Pharmacol 47:103–114
Moncada S, Gryglewsky R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665
Pomerantz K, Sintetos A, Ramwell P (1978) The effect of prostacyclin on the human umbilical artery. Prostaglandins 15:1035–1044
Chapeau CE, White RP (1979) Effects of prostacyclin on the canine isolated basilar artery. Prostaglandins 17:573–580
Schrör K, Rösen P (1979) Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries. Naunyn Schmiedeberg's Arch Pharmacol 306:101–103
Ogletree ML, Smith BJ, Lefer AM (1978) Actions of prostaglandins on isolated perfused cat coronary arteries. Am J Physiol 235:400–406
Bern MB (1978) Platelet functions in diabetes mellitus. Diabetes 27:342–352
Colwell JA, Chambers A, Laimins M (1975) Increased platelet aggregation in early diabetes. Diabetes 24:684–687
Owen MP, Carrier GO (1979) Alteration in vascular smooth muscle sensitivity to vasoconstrictor agents by streptozotocin induced diabetes. Proc West Pharmacol Soc 22:363–366
del Castillo EJ, Galli ME, Roldán A, Rietti CT, Houssay BA (1965) Decrease in Ketonemia due to infusion of lipids in pancreatectomized dogs. Diabetes 14:33–35
Borda L, Schuchleib R, Henry P (1977) Effect of potassium on isolated canine coronary arteries. Circ Res 41:778–786
Sterin-Bora L, Gimeno AL, Gimeno MF (1974) Frequencyforce relationship on isolated rat and guinea pig atria. Effect of cholinergic and adrenergic receptor antagonists. Proc Soc Exp Biol Med 145:1151–1157
Gimeno MF, Sterin-Borda L, Borda ES, Lazzari MA, Gimeno AL (1980) Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries. Prostaglandins 19:907–916
Borda ES, Lazzari MA, Gimeno MF, Gimeno AL (1980) Human platelet rich plasma and human serum protects from inactivation the antiaggregatory capacity of prostacyclin-like material (PGI2) produced by the rat stomach fundus. Prostaglandins 19:899–905
Dusting GJ, Chapple DJ, Hughes R, Moncada S, Vane JR (1978a Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetized dogs. Cardiovasc Res 12:720–730
Dusting GJ, Moncada S, Vane JR (1978b) Recirculation of prostacyclin (PGI2) in the dog. Br J Pharmacol 64:315–320
Fitzpatrick TM, Alter I, Corey EJ, Ramwell PW, Rose JC, Kot PA (1978) Cardiovascular responses to PGI2 (prostacyclin) in the dog. Circulation Res 42:192–194
Borda LS, Canga L, Gimeno MF, Gimeno AL (1979) Adrenergic mechanism subserving a positive inotropism and chronotropism of prostacyclin on isolated rat atria. Experientia 35:529–531
Borda ES, Agostini MC, Sterin-Speziale N, Gimeno MF, Gimeno AL (1979) Spontaneous contractile activity of isolated ovarian human vein. Influence of prostacyclin (PGI2). Prostaglandins 18:829–935
Herman AG, Verbeurens TJ, Moncada S, Vane JR, Vanhoutte PM (1978) Effect of prostacyclin on myogenic activity and adrenergic neuroeffector interaction in isolated canine veins. Arch Int Pharmacodyn Ther 232:340–341
Rösen P, Schrör K (1980) Increased prostacyclin release from perfused hearts of acutely diabetic rats. Diabetologia 18:391–394
Harrison HE, Reece AH, Johnson M (1978) Decreased vascular prostacyclin in experimental diabetes. Life Sci 33:351–356
Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H (1979) Decreased vascular prostacyclin in juvenile onset diabetics. N Engl J Med 300:366–367
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sterin-Borda, L., Borda, E.S., Gimeno, M.F. et al. Contractile activity and prostacyclin generation in isolated coronary arteries from diabetic dogs. Diabetologia 22, 56–59 (1982). https://doi.org/10.1007/BF00253871
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00253871